Dr Simone discusses How To Stop School Shootings,
How To Secure A Classroom Door,
Antidepressants are Not Effective and Can Induce Violence,
Simone Super Energy
For every $1 million donated by Big Pharma to help patients get high priced drugs, $21 million can be generated back to Big Pharma.
“In 90% of all school shootings, the shooters either were on or had taken psychotropic drugs” that can induce violence. Dr Simone presents a Six Point Prevention Plan to stop the slaughtering of our children by taking seriously people who make threats, especially those taking psychiatric medicines, and intervening early. This is much more effective to stop school shootings.
SIMONE SUPER ENERGY, HEPATITIS C, KIDSTART PREVENTION PROGRAM, FLU, OPIOID CRISIS – ERSKINE OVERNIGHT INTERVIEW
Interview with ERSKINE OVERNIGHT explores: OPIOID CRISIS, DANGERS OF ENERGY DRINKS, STATINS, FLU, PROTONS, SIMONE HEALTH INSURANCE ADVANTAGE, SLEEP APNEA
Doctors are told in sponsored seminars that the hepatitis C drugs actually cure the disease. However, a 2017 Cochrane review of 138 randomized trials shows that these drugs do not extend life or improve the quality of life
Through their privately held pharmaceutical company, Purdue Pharma, the Sacklers chose to manufacture and market a highly addictive drug, OxyContin, and made billions of dollars from it.
Big Pharma raise prices each year, or when a new indication is granted by the FDA, or by other ways. A new way of raising prices is the use of trickery.
Amgen, the maker of evolocumab (Repatha) funded the research, paid EVERY author on the paper, led by Harvard researchers, and the findings were published in the prestigious New England Journal of Medicine May 4, 2017. If you take the drug, evolocumab (Repatha), your LDL will go down but you won’t live any longer. IT’S ALL ABOUT INFLAMMATION AND OXIDATION.
GlaxoSmithKline chief executive officer Andrew Witty said the pharmaceutical industry’s estimate of $1+ billion in average cost to develop a drug is “one of the great myths of the industry,” according to Reuters March 15, 2013. Cost to discover new drugs is about 15% of what is estimated and 1.3% of revenues after deducting taxpayer subsidies.
The high cost of cancer drugs is unsustainable and is a real threat to our health care system. Big Pharma uses several tactics: Pay-for-Delay, Product Hopping, no importation of prescription drugs.
Big Pharma can dodge paying their fair share of taxes while enjoying aggressively priced products in the United States. The U.S. Government has always protected Big Pharma.
At best, flu vaccines might be effective against only influenza A and B, which represent about 10% of all circulating viruses that cause the flu like syndrome. The CDC and NIH indicate that the current live attenuated flu vaccine is ineffective.
The Trans Pacific Partnership is a massive trade deal soon to be completed. The text of the international trade deal is a closely held secret. Members of the US Congress can read it only if they agree to leave all recording devices, pens and their staffers out of the room. The Trans Pacific Partnership is a bad trade deal for all Americans and the world at large. If the Congress does this, our health policy will be compromised for years.
The best part of the 21st Century Cures Act if enacted into law would be for an increased NIH funding. But the rest could lead to approval of drugs and devices that are not safe and not effective.
The federal government, the biggest payer of cancer care, made cancer costs soar because Medicare pays an extra $6500 a year when chemotherapy is given to a patient in a hospital owned facility. Private insurers also pay a higher premium for care delivered in a hospital setting. The costs will keep spiraling upward because of Government intrusion and clever lobbyists, forcing cancer patients from private practitioners to hospital owned facilities incurring much higher costs.
Patient-assistance programs effectively: (1) increase demand for the drug, (2) allow companies to charge higher prices and thereby gain higher profits, and, (3) enjoy tremendous public-relations benefits.